Cultural level appears to be a critical factor in the decision process of allergen-specific immunotherapy (SIT) both for doctors and patients. Thus, appropriate educational programs should be carried out to increase the number of allergic patients to be treated with SIT.
BousquetJLockeyRMailingHJ. World Health Organization position paper. Allergen immunotherapy: therapeutical vaccines for allergic diseases. Allergy1998; 53(S):1–45.
2.
The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISSAC. Lancet1998; 351:1225–36.
3.
BousquetJVan CauwenbergP. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol2001; 108(S):146–385.
Customer satisfaction evaluation and quality of assessment by CATI methodology. University of Florence Publication by the Statistics Department “Giuseppe Parenti”, 2000, Florence.
6.
MantovaniLGBettoncelliGCricelliC. Allergic rhinitis in the Italian population evaluated through the national database of general practitioners. Allergy2007; 62:569–70.
